Drug-induced liver injury (DILI) is a common and underestimated cause of liver disease.
Several drugs and other xenobiotics can be the cause of different clinicopathologic patterns …

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed
countries. Its frequency is increasing in the general population mostly due to the widespread …

Drug-induced liver diseases (DILD) are clinico-pathologic patterns of liver injury caused by
drugs or other foreign compounds. Steatohepatitis is a rare form of DILD, and drugs account …

Over the past decades, many drugs have been identified, that can potentially induce
steatohepatitis in the predisposed individual. Classically this has been incriminated to …

Introduction: Hepatic steatosis is the histological observation of numerous lipid inclusions
due to an excess accumulation of triacylglycerols. They are a concern with new therapeutic …

Metabolic dysfunction-associated fatty liver disease (commonly known as MAFLD) impacts
global health in epidemic proportions, and the resulting morbidity, mortality and economic …

Background Nonalcoholic fatty disease (NAFLD) is the most common liver disease, since it
is strongly associated with obesity and metabolic syndrome pandemics. NAFLD may affect …

Drug-induced liver injury (DILI) due to the use of prescription and non-prescription
medication by HIV-positive and HIV-negative patients is one of the main causes of acute …

Obesity is commonly associated with nonalcoholic fatty liver (NAFL), a benign condition
characterized by hepatic lipid accumulation. However, NAFL can progress in some patients …

Drug-induced steatosis (DIS) and drug-induced steatohepatitis (DISH) are two of several
types of drug-induced liver injury (DILI). They can be caused by various drugs and may …